NO20025329L - Virulensgener, proteiner og deres anvendelse - Google Patents

Virulensgener, proteiner og deres anvendelse

Info

Publication number
NO20025329L
NO20025329L NO20025329A NO20025329A NO20025329L NO 20025329 L NO20025329 L NO 20025329L NO 20025329 A NO20025329 A NO 20025329A NO 20025329 A NO20025329 A NO 20025329A NO 20025329 L NO20025329 L NO 20025329L
Authority
NO
Norway
Prior art keywords
genes
proteins
virulence genes
virulence
products
Prior art date
Application number
NO20025329A
Other languages
English (en)
Other versions
NO20025329D0 (no
Inventor
Christoph Tang
Original Assignee
Microscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microscience Ltd filed Critical Microscience Ltd
Publication of NO20025329D0 publication Critical patent/NO20025329D0/no
Publication of NO20025329L publication Critical patent/NO20025329L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/36—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20025329A 2000-05-08 2002-11-06 Virulensgener, proteiner og deres anvendelse NO20025329L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0011108.8A GB0011108D0 (en) 2000-05-08 2000-05-08 Virulence gene and protein and their use
PCT/GB2001/002003 WO2001085772A2 (en) 2000-05-08 2001-05-08 Virulence genes, proteins, and their use

Publications (2)

Publication Number Publication Date
NO20025329D0 NO20025329D0 (no) 2002-11-06
NO20025329L true NO20025329L (no) 2003-01-06

Family

ID=9891203

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025329A NO20025329L (no) 2000-05-08 2002-11-06 Virulensgener, proteiner og deres anvendelse

Country Status (16)

Country Link
US (2) US20040087770A1 (no)
EP (2) EP1908839A3 (no)
JP (1) JP2003532404A (no)
KR (3) KR20030032948A (no)
CN (2) CN1840665A (no)
AT (1) ATE382056T1 (no)
AU (1) AU776508B2 (no)
CA (1) CA2408738A1 (no)
CZ (1) CZ20023642A3 (no)
DE (1) DE60132084T2 (no)
GB (1) GB0011108D0 (no)
HU (1) HUP0302481A2 (no)
NO (1) NO20025329L (no)
NZ (3) NZ522277A (no)
RU (2) RU2252224C2 (no)
WO (1) WO2001085772A2 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996017951A2 (en) 1994-12-09 1996-06-13 Rpms Technology Limited Identification of genes responsible for in vivo survival of microorganisms
DK1108034T3 (da) 1998-09-04 2008-11-10 Emergent Product Dev Uk Ltd Svækkede salmonella SPI2-mutanter som antigenbærere
DK1163343T3 (da) 1999-03-12 2010-04-19 Glaxosmithkline Biolog Sa Neisseria meningitidis antigene polypeptider, tilsvarende polynukleotider og beskyttende antistoffer
GB9910812D0 (en) 1999-05-10 1999-07-07 Microscience Ltd Vaccine composition
EP2255826B1 (en) * 2002-08-02 2016-04-13 GlaxoSmithKline Biologicals S.A. Neisserial vaccine compositions comprising a combination of antigens
GB0330007D0 (en) * 2003-12-23 2004-01-28 Imp College Innovations Ltd Vaccines
CN101180079B (zh) 2005-04-08 2012-07-18 惠氏公司 多价肺炎球菌多糖-蛋白质缀合物组合物
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
EP2573080A1 (en) * 2007-09-27 2013-03-27 The United States of America, as Represented by the Secretary, Department of Health and Human Services Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
US8703153B2 (en) 2008-06-16 2014-04-22 Prokarium Ltd. Salmonella vectored vaccines against Chlamydia and methods of use
GB0816447D0 (en) 2008-09-08 2008-10-15 Glaxosmithkline Biolog Sa Vaccine
JP2013522177A (ja) * 2010-03-11 2013-06-13 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム グラム陰性細菌性、例えば髄膜炎菌性の感染または疾患に対する免疫原性組成物またはワクチン
CN111118043B (zh) * 2020-01-13 2022-07-05 吉林大学 一种苦豆子SaMET6基因克隆及其应用
CN116042562B (zh) * 2022-03-11 2023-10-20 山东恒鲁生物科技有限公司 重组酵母菌及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98837A0 (en) * 1990-07-19 1992-07-15 Merck & Co Inc Pharmaceutical compositions comprising proteins from the outer membrane of neisseria meningitidis and their use to increase the immune response
US5338664A (en) * 1992-12-04 1994-08-16 American Cyanamid Company Assay for detection of bacterial iron transport inhibitors
US6121037A (en) * 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
WO1996017951A2 (en) * 1994-12-09 1996-06-13 Rpms Technology Limited Identification of genes responsible for in vivo survival of microorganisms
FR2751000B1 (fr) * 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
WO1998017805A2 (en) * 1996-10-24 1998-04-30 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, c/o Centers for Disease Control and Prevention, Technology Transfer Office Invasion associated genes from neisseria meningitidis serogroup b
GB9711964D0 (en) * 1997-06-09 1997-08-06 Medical Res Council Live attenuated vaccines
CN1204253C (zh) * 1997-08-15 2005-06-01 乌得勒支大学 奈瑟氏球菌乳铁蛋白结合蛋白
CA2308606A1 (en) * 1997-11-06 1999-05-20 Chiron S.P.A. Neisserial antigens
AU3968599A (en) * 1998-04-29 1999-11-16 American Cyanamid Company Vaccines containing recombinant pilin against Neisseria Gonorrhoeae or Neisseria Meningitidis
GB9811260D0 (en) * 1998-05-26 1998-07-22 Smithkline Beecham Biolog Novel compounds
MXPA01003557A (es) * 1998-10-09 2004-04-05 Chiron Corp Secuencias genomicas de neisseria y metodos para su uso.
US6610836B1 (en) * 1999-01-29 2003-08-26 Genome Therapeutics Corporation Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics
AU780308B2 (en) * 1999-04-30 2005-03-17 J. Craig Venter Institute, Inc. Neisseria genomic sequences and methods of their use

Also Published As

Publication number Publication date
NZ522277A (en) 2004-05-28
CZ20023642A3 (cs) 2003-04-16
RU2252224C2 (ru) 2005-05-20
HUP0302481A2 (hu) 2003-10-28
EP1287024B1 (en) 2007-12-26
KR20080080069A (ko) 2008-09-02
GB0011108D0 (en) 2000-06-28
CA2408738A1 (en) 2001-11-15
AU776508B2 (en) 2004-09-09
CN1427892A (zh) 2003-07-02
DE60132084T2 (de) 2008-12-11
DE60132084D1 (de) 2008-02-07
EP1908839A3 (en) 2008-07-16
WO2001085772A2 (en) 2001-11-15
ATE382056T1 (de) 2008-01-15
RU2005101623A (ru) 2006-07-10
EP1908839A2 (en) 2008-04-09
AU5242201A (en) 2001-11-20
JP2003532404A (ja) 2003-11-05
EP1287024A2 (en) 2003-03-05
US20080241151A1 (en) 2008-10-02
NZ532297A (en) 2005-07-29
KR20030032948A (ko) 2003-04-26
CN1840665A (zh) 2006-10-04
US20040087770A1 (en) 2004-05-06
NZ549068A (en) 2008-03-28
NO20025329D0 (no) 2002-11-06
WO2001085772A3 (en) 2002-03-28
KR20070102447A (ko) 2007-10-18

Similar Documents

Publication Publication Date Title
NO20025329L (no) Virulensgener, proteiner og deres anvendelse
IS6895A (is) Aðferð til að bera kennsl á, einangra og vinna mótefnavaka við ákveðnum sjúkdómsvaldi
DE69932717D1 (de) Methoden und produkte zur induzierung mukosaler immunität
CY1107950T1 (el) Νεϊσσεριακες συνθεσεις εμβολιου και μεθοδοι
DE69926729D1 (de) Transgenes kaninchen, dass ein funktionelles menschliches lipoprotein(a) exprimiert
NO20032111L (no) Nye medikamentblandinger basert pa tiotropium-salter og pa salmeterol-salter
NO20050063L (no) 2-heteroaryl karboksamider
NZ515936A (en) Antigenic Neisserial peptides
GB0121998D0 (en) Attenuated bacteria useful in vaccines
NO20023006L (no) Virulens gener, proteiner og deres anvendelse
DK1471936T3 (da) HIV-Vaccine og fremgangsmåde til anvendelse
DE60011560D1 (de) Salmonella Impfstoff, der keinen Antikörper gegen Flagellin oder gegen Flagella induziert
NO20062469L (no) Streptococcus phocae vaksine
NO20013102D0 (no) Gener, proteiner og deres anvendelse
DE602005025202D1 (de) Subtilasevarianten mit veränderter immunogenität
DE60126765D1 (de) Virulenz gene, proteine, und ihre verwendung
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
WO2002016612A3 (en) Genes and proteins, and their uses
DK1074266T3 (da) Levende svækkede bakterier til anvendelse i vaccine
DK1763515T3 (da) 4-Triflourmethoxyphenoxybenzen-4'-sulfonsyrer, fremgangsmåde til deres fremstilling og anvendelse i lægemidler
DK1313850T3 (da) Nucleinsyre og tilsvarende protein med navnet 85PB3 anvendelige til behandling og påvisning af cancer
DK1423429T3 (da) Antistoffer mod caspase-8 og deres fremstilling og anvendelse
WO2001057075A3 (en) Virulence genes, proteins, and their use
DE60024977D1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
BR0308180A (pt) protéinas de superfìcie de leptospira

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application